Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Reduced BCG Dwell-Time in High Risk NMIBC
NCT04701151Phase 4Active, not recruiting
- Start
- Feb 2021
- Primary completion
- Dec 2026
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 3
01
Overview
A Phase 4 trial of bcg vaccine in non-muscle-invasive bladder cancer (NMIBC). Started Feb 2021; status: active, not recruiting.
02
Drugs
bcg vaccine
03
Conditions
non-muscle-invasive bladder cancer (NMIBC)
Beyond the preview
Go deeper on NCT04701151.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04701151.